137 related articles for article (PubMed ID: 29408555)
1. Nepafenac loaded silica nanoparticles dispersed in-situ gel systems: Development and characterization.
Paulsamy M; Ponnusamy C; Palanisami M; Nackeeran G; Paramasivam S; Sugumaran A; Kandasamy R; Natesan S; Palanichamy R
Int J Biol Macromol; 2018 Apr; 110():336-345. PubMed ID: 29408555
[TBL] [Abstract][Full Text] [Related]
2. In Situ Gel Formulation for Enhanced Ocular Delivery of Nepafenac.
Shelley H; Rodriguez-Galarza RM; Duran SH; Abarca EM; Babu RJ
J Pharm Sci; 2018 Dec; 107(12):3089-3097. PubMed ID: 30170009
[TBL] [Abstract][Full Text] [Related]
3. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
5. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
6. Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation.
Shelley H; Grant M; Smith FT; Abarca EM; Jayachandra Babu R
AAPS PharmSciTech; 2018 Aug; 19(6):2554-2563. PubMed ID: 29948988
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J
Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery.
Tian Z; Xu Y; Zhu Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731
[TBL] [Abstract][Full Text] [Related]
9. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
Morsi N; Ghorab D; Refai H; Teba H
Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
12. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
Ke TL; Graff G; Spellman JM; Yanni JM
Inflammation; 2000 Aug; 24(4):371-84. PubMed ID: 10850858
[TBL] [Abstract][Full Text] [Related]
13. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
Sharma S; Lohan S; Murthy RS
Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
[TBL] [Abstract][Full Text] [Related]
15. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
17. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
Gonzalez-Pizarro R; Carvajal-Vidal P; Halbault Bellowa L; Calpena AC; Espina M; García ML
Colloids Surf B Biointerfaces; 2019 Mar; 175():365-374. PubMed ID: 30554015
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration.
Russo E; Gaglianone N; Baldassari S; Parodi B; Croce I; Bassi AM; Vernazza S; Caviglioli G
Colloids Surf B Biointerfaces; 2016 Jul; 143():88-96. PubMed ID: 26998870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]